Styrian Vitamin D Hypertension Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02136771

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02136771
  • EudraCT 2009-018125-70
Other papers using this trial's data
  • Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial Journal of clinical hypertension (Greenwich, Conn.), 2016-07 DOI, PubMed 27098193, PMC8032175 Not in the PMC Open Access subset.
  • Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension The Journal of steroid biochemistry and molecular biology, 2018-01 DOI, PubMed 28027911
  • Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial Hypertension (Dallas, Tex. : 1979), 2015-06 DOI, PubMed 25801871
  • Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients Nutrition, metabolism, and cardiovascular diseases : NMCD, 2021-10-28 DOI, PubMed 34629245

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02136771. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2014-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Styrian Vitamin D Hypertension Trial
Condition
Arterial Hypertension
Condition
Vitamin D Deficiency
Intervention (Dietary supplement)
Vitamin D3
Intervention (Dietary supplement)
Placebo
Lead sponsor
Medical University of Graz (class: other)

Record details

Record id
cardio:ct-nct02136771
Content hash
5c81560c647a75ffc8f3ee71443de54c069473512737bade5a56a2c6cdb45fc2